Van ECK Associates Corp boosted its stake in TransAlta Co. (NYSE:TAC – Free Report) (TSE:TA) by 7.5% in the fourth quarter, ...

CIBC analyst Mark Jarvi maintained a Buy rating on TransAlta (TAC – Research Report) today and set a price target of C$19.50. The company’s ...

TransAlta Corporation faces stock declines and challenges but focuses on renewables & strategic growth. Evaluate its ...

In a report released yesterday, Maurice Choy from RBC Capital maintained a Buy rating on TransAlta (TAC – Research Report), with a price target ...

Full Year 2024 Results Key Financial Results Revenue: CA$2.85b (down 15% from FY 2023).

TransAlta Corp (TAC) reports robust earnings with significant EBITDA growth and strategic acquisitions, while navigating challenges in power pricing and operational costs.

Cibc World Mkts upgraded shares of TransAlta (NYSE:TAC – Free Report) (TSE:TA) from a hold rating to a strong-buy rating in a ...

TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today (Feb 20) reported its financial results for the fourth quarter and year ended Dec. 31, 2024.

Gain key insights from TransAlta's Q4 2024 earnings call. Discover strong EBITDA, growth plans, and forecasts.

Bausch Health shares jumped by more than 11% to 10.31 Canadian dollars ($7.24) after the Laval, Quebec-based company reported better-than-expected revenue and earnings in the fourth quarter and said ...

China’s annual Singles’ Day sales event, a nationwide shopping festival in October and November, often viewed as a barometer ...

TransAlta Corp. raised its dividend as it reported a smaller loss in its fourth quarter compared with a year earlier.